• Glycosylated recombinant human granulocyte colony-stimulating factor (rHuG-CSF) and macrophages.
  • Prevention of febrile neutropenia and its related complications, in patients undergoing chemotherapy and mobilization of peripheral blood stem cells (PBSC) for bone marrow transplantation.
PRESENTATION:

Package containing one vial with lyophilized powder, containing 263 mcg of lenograstim + 1 prefilled syringe with diluent + 2 disposable needles.

The material on this website is oriented to healthcare professionals only. It aims to provide information on how to use these medications efficiently, and to spread the knowledge of these products. This information does not substitute medical diagnosis, advice and indication. Biosidus recommends asking a doctor first.

The texts referring to our prescription drugs abide by the National Administration of Drugs, Foods and Medical Devices (ANMAT) in the Argentine Republic approved guidelines.

DOWNLOAD BROCHURE